Table 6.
Impact of mNGS on PCP patients’ antimicrobial therapy
| Modififications(n [%]) | PCP patients (n = 17) % |
|---|---|
| Remove agent | 8(47.0) |
| Reduce antimicrobial spectrum | 4(23.5) |
| Add agent | 5(29.4) |
| Add TMP-SMZ | 14(82.4) |
| Add caspofungin | 1(5.9) |
| No change | 2(11.8) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.